3Smith BW,Adams LA. Nonalcoholic fatty liver disease and dia- betes mellitus: pathogenesis and treatment[J]. Nat Rev Endocrinol, 2011,7(8) :456-465.
4Kantartzis K,Machann J,Schick F,et al. The impact of liver fat vs visceral fat in determining categories of prediabetes[J]. Diabetolo- gia,2010,53(5) :882-889.
5Targher G, Byme CD. Clinical Review : Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications[J]. J Clin Endocrinol Metab, 2013,98 (2) : 483-495.
6Samuel VT, Liu ZX, Qu X, et al. Mechanism of hepatic insulin re- sistance in non-alcoholic fatty liver disease [J]. J Biol Chem, 2004,279(31 ) :32345-32353.
7Gao Z,Zhang J,Kheterpal I,et al. Sirtuin 1 (SIRT1) protein degra- dation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity[J]. J Biol Chem, 2011,286 (25) : 22227-22234.
8Ix JH, Sharma K. Mechanisms linking obesity, chronic kidney dis- ease,and fatty liver disease : the roles of fetuin-A ,adiponectin, and AMPK[J]. J Am Soc Nephrol,2010,21 (3):406-412.
9Bugianesi E ,Gastaldelli A,Vanni E ,et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms[J]. Diabetologia,2005,48(4) :634-642.
10Odegaard JI, Chawla A. Alternative macrophage activation and metabolism[J]. Annu Rev Pathol, 2011,6 : 275-297.
